Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impacts of Mitochondrial-targeted Antioxidant on Leg Function, Leg Blood Flow and Skeletal Muscle Mitochondrial Function in Peripheral Artery Disease Patients

NCT03506633 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT03506633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03506633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impacts of Mitochondrial-targeted Antioxidant on Leg Function, Leg Blood Flow and Skeletal Muscle Mitochondrial Function in Peripheral Artery Disease Patients
Lead sponsor
University of Nebraska
Phase
Not applicable
Overall status
Completed
Start date
September 5, 2018
Completion date
January 17, 2022
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease, peripheral artery disease